Cargando…
A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation
Multifocal papillary thyroid carcinoma (PTC) is common and the number of tumor foci rarely exceeds ten. The mechanism of multifocal disease is debated, with the two main hypotheses consisting of either intrathyroidal metastatic spread from a single tumor or independent multicentric tumorigenesis fro...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432975/ https://www.ncbi.nlm.nih.gov/pubmed/30884463 http://dx.doi.org/10.1530/EDM-19-0006 |
_version_ | 1783406224318922752 |
---|---|
author | Pancer, Jill Mitmaker, Elliot Ajise, Oluyomi Tabah, Roger How, Jacques |
author_facet | Pancer, Jill Mitmaker, Elliot Ajise, Oluyomi Tabah, Roger How, Jacques |
author_sort | Pancer, Jill |
collection | PubMed |
description | Multifocal papillary thyroid carcinoma (PTC) is common and the number of tumor foci rarely exceeds ten. The mechanism of multifocal disease is debated, with the two main hypotheses consisting of either intrathyroidal metastatic spread from a single tumor or independent multicentric tumorigenesis from distinct progenitor cells. We report the case of a 46-year-old woman who underwent total thyroidectomy and left central neck lymph node dissection after fine-needle aspiration of bilateral thyroid nodules that yielded cytological findings consistent with PTC. Final pathology of the surgical specimen showed an isthmic dominant 1.5 cm classical PTC and over 30 foci of microcarcinoma, which displayed decreasing density with increasing distance from the central lesion. Furthermore, all malignant tumors and lymph nodes harbored the activating BRAF V600E mutation. The present case highlights various pathological features that support a mechanism of intraglandular spread, namely a strategic isthmic location of the primary tumor, radial pattern of distribution and extensive number of small malignant foci and BRAF mutational homogeneity. LEARNING POINTS: Multifocal papillary thyroid carcinoma (PTC) is commonly seen in clinical practice, but the number of malignant foci is usually limited to ten or less. There is no clear consensus in the literature as to whether multifocal PTC arises from a single or multiple distinct tumor progenitor cells. Strategic location of the dominant tumor in the thyroid isthmus may favor intraglandular dissemination of malignant cells by means of the extensive lymphatic network. An important pathological finding that may be suggestive of intrathyroidal metastatic spread is a central pattern of distribution with a reduction in the density of satellite lesions with increasing distance from the dominant focus. PTCs originating from the isthmus with intraglandular metastatic dissemination behave more aggressively. As such, a more aggressive treatment course may be warranted, particularly with regard to the extent of surgery. |
format | Online Article Text |
id | pubmed-6432975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-64329752019-03-27 A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation Pancer, Jill Mitmaker, Elliot Ajise, Oluyomi Tabah, Roger How, Jacques Endocrinol Diabetes Metab Case Rep Insight into Disease Pathogenesis or Mechanism of Therapy Multifocal papillary thyroid carcinoma (PTC) is common and the number of tumor foci rarely exceeds ten. The mechanism of multifocal disease is debated, with the two main hypotheses consisting of either intrathyroidal metastatic spread from a single tumor or independent multicentric tumorigenesis from distinct progenitor cells. We report the case of a 46-year-old woman who underwent total thyroidectomy and left central neck lymph node dissection after fine-needle aspiration of bilateral thyroid nodules that yielded cytological findings consistent with PTC. Final pathology of the surgical specimen showed an isthmic dominant 1.5 cm classical PTC and over 30 foci of microcarcinoma, which displayed decreasing density with increasing distance from the central lesion. Furthermore, all malignant tumors and lymph nodes harbored the activating BRAF V600E mutation. The present case highlights various pathological features that support a mechanism of intraglandular spread, namely a strategic isthmic location of the primary tumor, radial pattern of distribution and extensive number of small malignant foci and BRAF mutational homogeneity. LEARNING POINTS: Multifocal papillary thyroid carcinoma (PTC) is commonly seen in clinical practice, but the number of malignant foci is usually limited to ten or less. There is no clear consensus in the literature as to whether multifocal PTC arises from a single or multiple distinct tumor progenitor cells. Strategic location of the dominant tumor in the thyroid isthmus may favor intraglandular dissemination of malignant cells by means of the extensive lymphatic network. An important pathological finding that may be suggestive of intrathyroidal metastatic spread is a central pattern of distribution with a reduction in the density of satellite lesions with increasing distance from the dominant focus. PTCs originating from the isthmus with intraglandular metastatic dissemination behave more aggressively. As such, a more aggressive treatment course may be warranted, particularly with regard to the extent of surgery. Bioscientifica Ltd 2019-03-18 /pmc/articles/PMC6432975/ /pubmed/30884463 http://dx.doi.org/10.1530/EDM-19-0006 Text en © 2019 The authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (http://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Insight into Disease Pathogenesis or Mechanism of Therapy Pancer, Jill Mitmaker, Elliot Ajise, Oluyomi Tabah, Roger How, Jacques A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation |
title | A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation |
title_full | A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation |
title_fullStr | A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation |
title_full_unstemmed | A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation |
title_short | A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation |
title_sort | thyroid gland with over 30 foci of papillary thyroid carcinoma with activating braf v600e mutation |
topic | Insight into Disease Pathogenesis or Mechanism of Therapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432975/ https://www.ncbi.nlm.nih.gov/pubmed/30884463 http://dx.doi.org/10.1530/EDM-19-0006 |
work_keys_str_mv | AT pancerjill athyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT mitmakerelliot athyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT ajiseoluyomi athyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT tabahroger athyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT howjacques athyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT pancerjill thyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT mitmakerelliot thyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT ajiseoluyomi thyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT tabahroger thyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation AT howjacques thyroidglandwithover30fociofpapillarythyroidcarcinomawithactivatingbrafv600emutation |